B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

ADRA1B

MOLECULAR TARGET

adrenoceptor alpha 1B

UniProt: P35368NCBI Gene: 14741 compounds

ADRA1B (adrenoceptor alpha 1B) is targeted by 41 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting ADRA1B

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
1Phentolamine3.7140
2Yohimbine3.1823
3Tamsulosin3.1422
4Idazoxan2.9418
5Norepinephrine Precursor of epinephrine that is secreted by2.8917
6Clonidine2.4811
7Oxymetazoline2.309
8Mianserin2.208
9Buspirone2.208
10Epinephrine2.208
11Piperoxan2.208
12Indoramin1.956
13Phenylephrine1.956
14Quetiapine Fumarate1.795
15Aripiprazole1.795
16Fluoxetine1.614
17Naphazoline1.614
18Dihydroergotamine1.393
19Tolazoline1.393
20Carvedilol1.102
21Dihydroergotamine1.102
22eliprodil1.102
23Methoxamine1.102
24Phenoxybenzamine1.102
25Platelet Activating Factor1.102
26Trazodone1.102
27Amlodipine0.691
28Losartan0.691
29amn0820.691
30Atenolol0.691
31Cyproheptadine0.691
32Dexmedetomidine0.691
33Guanabenz0.691
34Hydroxyzine0.691
35Isoproterenol Isopropyl analog of EPINEPHRINE; beta-sympathomimetic that acts on0.691
36Labetalol0.691
37Lisuride0.691
38Loxapine0.691
39Lysergic Acid Diethylamide Semisynthetic derivative of ergot (Claviceps purpurea). It has complex effects on serotonergic systems including antagonism at some peripheral serotonin receptors, both agonist and antagonist actions at central nervous system serotonin receptors, and possibly effects on serotonin turnover. It is0.691
40Metergoline0.691
41Pergolide0.691

About ADRA1B as a Drug Target

ADRA1B (adrenoceptor alpha 1B) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 41 compounds with documented ADRA1B interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

ADRA1B inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.